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ABSTRACT
Alternative polyadenylation leads to mRNAs with
variable 30 ends. Since a 30-untranslated region
(30-UTR) often contains cis elements that impact
stability or localization of mRNA or translation,
selection of poly(A) sites in a 30-UTR is regulated
in mammalian cells. However, the molecular basis
for alternative poly(A) site selection within a 30-UTR
has been unclear. Here we show involvement of
cleavage factor Im (CFIm) in poly(A) site selection
within a 30-UTR. CFIm is a heterodimeric 30 end-
processing complex, which functions to assemble
other processing factors on pre-mRNA in vitro.W e
knocked down 25 kDa subunit of CFIm (CFIm25) in
HeLa cells and analyzed alternative poly(A) site
selection of TIMP-2, syndecan2, ERCC6 and DHFR
genes by northern blotting. We observed changes in
the distribution of mRNAs in CFIm25 depleted cells,
suggesting a role for CFIm in alternative poly(A)
site selection. Furthermore, tissue specific analysis
demonstrated that the CFIm25 gene gave rise to
1.1, 2.0 and 4.6 kb mRNAs. The 4.6 kb mRNA was
ubiquitously expressed, while the 1.1 and 2.0 kb
mRNAs were expressed in a tissue specific manner.
We found three likely poly(A) sites in the CFIm25
30-UTR, suggesting alternative polyadenylation. Our
results indicate that alternative poly(A) site selec-
tion is a well-regulated process in vivo.
INTRODUCTION
Numerous genes in mammalian species undergo alternative
polyadenylation, which results in transcripts with variable
30 ends (1,2). Alternative poly(A) sites can be located in
the last or 30-most exon, giving rise to mRNAs with variable
30-untranslated region (30-UTR), or in a different exon,
resulting in protein products that vary at the C-terminus (1).
In addition, pre-mRNA 30 end processing contributes directly
to transcription termination, pre-mRNA splicing and mRNA
export (3,4). Many genes are reported to be subject to
alternative 30 end processing, and several lines of evidence
suggest that poly(A) site selection may be modulated devel-
opmentally or in a tissue speciﬁc manner (5), however the
fundamental mechanisms responsible for regulating alterna-
tive poly(A) site selection have not been elucidated.
Polyadenylation of eukaryotic mRNA occurs in a step-wise
process, which includes a speciﬁc cleavage at the 30 end of
nascent mRNA followed by an addition of a poly(A) tail.
Six factors, namely CPSF, CstF, CFIm, CFIIm (cleavage
factor II), PAP (poly(A) polymerase) and PABII (poly(A)
binding protein II) have been characterized to facilitate
the 30 end processing [reviewed in (6–8)]. The cleavage reac-
tion requires recognition by CPSF of AAUAAA hexamer
upstream of the cleavage site and by CstF of degenerate
GU- and U-rich sequences downstream of the cleavage site.
CFIm is an essential pre-mRNA 30 end-processing factor
unique to metazoans, which facilitates assembly of 30 end
processing factors on pre-mRNA in vitro (9). CFIm was
ﬁrst puriﬁed from HeLa cell nuclear extracts as four polypep-
tides of 25, 59, 68 and 72 kDa (CFIm25, CFIm59, CFIm68
and CFIm72, respectively). Subsequent studies revealed that
CFIm59, CFIm68, and CFIm72 are structurally related and
that CFIm can be reconstituted with CFIm68 and CFIm25
subunits, suggesting that CFIm is a heterodimer composed
of the small CFIm25 subunit and any one of the three larger
subunits (10). CFIm25 protein possesses a NUDIX domain
and CFIm68 and CFIm59 proteins possess C-terminal RS-
like alternating charge domains, similar to motifs seen in
the SR protein family, which functions in basal and regulated
pre-mRNA splicing. SELEX analysis has indicated that the
CFIm68/25 heterodimer preferentially binds the sequence
UGUAN (11). Sequence speciﬁc binding of CFIm to RNA
can direct the recruitment of the CPSF on pre-mRNA through
interaction with a CPSF subunit, hFip1 (12).
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poly(A) site selection. We knocked down CFIm25 in HeLa
cells, and analyzed, by northern blotting, alternative polyade-
nylation of several genes that have multiple poly(A) sites
within the 30-UTRs. We detected distributional changes in
mRNAs following CFIm25 knock-down, suggesting that
CFIm is involved in alternative polyadenylation. Further-
more, analysis of CFIm25 expression proﬁles in various
tissues revealed 1.1, 2.0 and 4.6 kb species of CFIm25
mRNA, which were likely derived from multiple poly(A)
signals within the CFIm25 30-UTR. We found that the
4.6 kb mRNA was ubiquitously expressed in human tissues,
while the 1.1 and 2.0 kb species were expressed in a tissue
speciﬁc manner.
MATERIALS AND METHODS
Antibodies
The entire ORF of CF1m25 was cloned into the expression
vector (pGEX-6P-1) and GST-CFIm25 protein was expressed
in Escherichia coli and puriﬁed by afﬁnity chromatography
on glutathione Sepharose (GE healthcare). a-CFIm25 rabbit
polyclonal antibody was raised against recombinant GST-
CFIm25. a-CstF64 (H-300) was purchased from Santa Cruz
and anti-actin (C4) was from Chemicon.
Cell culture and RNA interference
HeLa cells were cultured in DMEM supplemented with 10%
FBS and penicillin/streptomycin. For silencing experiments,
HeLa cells ( 2.0 · 10
5/ml) were transfected with small
interfering RNA duplexes (200 nM) using Oligofectamine
(Invitrogen), according to the manufacturer’s instructions,
and harvested 84 h after transfection to obtain total RNA.
Two siRNAs, GCAAUCGUCAAUGACCCAGUCUUGC
(siRNA-408) and AAAUGAUGGGUCCAUAUCCUGGUGC
(siRNA-613) targeting CF1m25, and control siRNA, CAGG-
AACGACUUGAUACGGCUACAG were selected and
synthesized by Invitrogen (Stealth RNAi).
Northern blotting
Brieﬂy, 2.5 mg of poly(A)
+ RNA were selected on oligo-dT
columns, glyoxylated, separated on a 1.0% agarose gel,
and transferred to a membrane (Hybond-N
+, Amersham).
The membrane was hybridized with a radio-labeled probe
(1.0–2.0 · 10
6 c.p.m./ml) for 2 h (or overnight) at 65 Ci n
PerfectHyb solution (TOYOBO) and analyzed by autoradio-
graphy. Probes were radio-labeled by BcaBEST labeling
(TAKARA). RNA size markers were purchased from Invitro-
gen (RNA ladder 0.24–9.5). For tissue speciﬁc analysis, a
human MTN blot (BD Biosciences) was analyzed.
30 RACE analysis and RT–PCR analysis
For 30 RACE experiments, 1 mg of total RNA, from control
HeLa cells or knocked-down cells, was reverse transcribed
with an adapter linked oligo-dT primer to the ﬁnal volume
of 20 ml following the manufacture’s procedure (30-Full
RACE Core Set, TAKARA). Then, 0.5 ml of the cDNA
was subjected to PCR (the reaction volume of 20 ml) with
a speciﬁc primer (4 pmol) and an adapter primer (1 pmol)
in the cycle number of 33 (for TIMP-2 gene) or 26 (for
GAPDH and CF1m25 genes).
For RT–PCR analysis of DHFR mRNA, 200 ng of
poly(A)
+ RNAs from control HeLa cells or CF1m25 knock-
down cells were reverse transcribed by SuperScriptIII
(Invitrogen) with oligo-dT primer, and then DHFR cDNA
fragments were augmented using DHFR primers. The DHFR
primers were designed in the ﬁrst and the last exons,
respectively.
The PCR products were resolved on a 1.0% agarose gel
and stained with ethidium bromide.
Nucleotides
Oligonucleotides were synthesized to amplify the cDNA frag-
ments of TIMP-2, syndecan2, ERCC6, DHFR and CF1m25
by PCR. The fragments were radio-labeled for probes in
northern blotting. TIMP-2 (forward) oligonucleotide was
also served as a speciﬁc primer (F1) in 30 RACE experiments.
DHFR oligonucleotides were also used in RT–PCR experi-
ments. The sequences were as follows: TIMP-2 (forward)
50-CGCAACAGGCGTTTTGCAAT-30; TIMP-2 (reverse)
50-TGGTGCCCGTTGATGTTCTT-30; syndecan2 (forward)
50-TGTACCTTGACAACAGCTCC-30; syndecan2 (reverse)
50-GCCAATAACTCCACCAGCAA-30; ERCC6 (forward)
50-AAATCAGTTGGCGTGCACAG-30; ERCC6 (reverse)
50-GCAGTATTCTGGCTTGAGTT-30; DHFR (forward) 50-
GTTGGTTCGCTAAACTGCAT-30; DHFR (reverse) 50-
TACTTAATGCCTTTCTCCTC-30; CF1m25 (forward) 50-
TCACTCAGTTCGGCAACAAG-30; CF1m25 (reverse) 50-
TGCAGCTACCAGCTTGTAAT-30. For the 30 RACE
experiments, the speciﬁc oligonucleotide of TIMP-2 gene
(F2) and an adapter primer were designed as follows:
F2 (TIMP-2) 50-CTGTTCGCTTCCTGTATGGT-30; Adapter
50-CTGATCTAGAGGTACCGGATCC-30.
RESULTS
Knock-down of CFIm25 in HeLa cells
CFIm is an essential 30 end processing factor facilitating
assembly of other processing factors on pre-mRNA templates
(10). Although precise studies in vitro have demonstrated
a critical role for CFIm in pre-mRNA cleavage, in vivo
function of CFIm has not been addressed. We knocked
down CFIm25 in HeLa cells to evaluate potential effects on
pre-mRNA cleavage.
First, we expressed a GST-fusion of CFIm25 protein in
E.coli and raised a rabbit polyclonal antibody against puriﬁed
GST-CFIm25. Figure 1A indicates that the antibody speciﬁc-
ally recognized CFIm25.
Next, we designed siRNAs (designated siRNA-408 and
siRNA-613) targeting CFIm25 to sequester CFIm function.
As CFIm is a heterodimer composed of CFIm25 and one other
larger subunit, we reasoned that depleting cells of CFIm25
protein by RNAi would block CFIm function. HeLa cells
were mock-transfected or independently transfected with
control siRNA, siRNA-408 and or siRNA-613 siRNAs, 84 h
later cells were harvested, and then whole cell extracts
were subjected to western blotting. Preliminary time course
analysis showed a  50% reduction in CFIm25 expression
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not shown). Expression levels recovered to 50% after 132 h
and to 80% after 156 h (data not shown). Knocked-down
cells appeared healthy and grew normally. As shown in
Figure 1B, either siRNA signiﬁcantly reduced CFIm25
protein levels. Actin levels, analyzed as a loading control,
were not altered by CFIm25 knock-down, indicating that
each siRNA speciﬁcally knocked down CFIm25.
We also analyzed CstF-64 expression in control cells and
knocked-down cells, since it was previously shown that
expression levels of CstF-64 inﬂuence alternative poly(A)
site selection (13–16). As shown in Figure 1B, CstF-64
expression levels were not changed by CFIm25 knock-down.
CFIm knock-down alters poly(A) site usage in
TIMP-2 gene
Based on in vitro observations, we predicted that RNAi-
mediated depletion of CFIm might reduce the efﬁcient
cleavage of pre-mRNA. To evaluate a role of CFIm for
pre-mRNA cleavage in vivo, we undertook northern blotting
and 30 RACE PCR to analyze mRNAs transcribed from genes
with multiple poly(A) sites in their 30-UTR.
We ﬁrst analyzed TIMP-2 gene, which is reported to have
two poly(A) sites in the 30-UTR (17), resulting in 1.2 and
3.8 kb mRNAs (Figure 2A). Total RNA was, 84 h after
siRNA transfection, were extracted from mock-transfected,
control siRNA transfected or knocked-down HeLa cells,
knocked-down or mock-transfected HeLa cells, poly(A)
+
RNA were selected on oligo-dT columns and the RNA
were analyzed by hybridization. As shown in Figure 2B,
signiﬁcant changes in TIMP-2 mRNA patterns were detected
in knock-down cells compared to control cells. In knock-
down cells, 1.2 kb mRNA levels were increased, while
3.8 kb decreased relative to controls (Figure 2B, lower
panel). Actin was analyzed as a loading control and also a
speciﬁc control (Figure 2C), indicating that the same amounts
of RNA were analyzed in control and knocked-down cells
and that polyadenylation of actin mRNA was not affected
by CF1mCFIm25 knock-down. The two siRNAs were inde-
pendently transfected to knock down CFIm25 and the same
results were obtained (Figure 2B, lanes 23 and 34), suggest-
ing that the results were reproducible. Moreover we repro-
duced the results at least three times. Because it is a
distributional change of mRNAs but not the appearance of
a novel mRNA that was observed by CFIm25 knock-down,
we prefer the idea suggest that CFIm is involved in alter-
native poly(A) site selection.
We further performed 30 RACE PCR experiments on
TIMP-2 gene. Total RNA were reverse-transcribed with
adapter linked oligo-dT primer and then 30 end was ampliﬁed
with an adapter primer and a speciﬁc primer by PCR. The
speciﬁc primers were designed (designated as F1 and F2)
as diagramed in Figure 2A. As shown in Figure 2E, F1 primer
and F2 primer yielded bands of about 700 and 900 bp,
corresponding to the proximal poly(A) site and the distal
poly(A) site, respectively. We found that the relative amounts
of the ampliﬁed bands of 700 bp increased in knocked-down
cells compared to control cells, and bands of 900 bp decreased
in knocked-down cells compared to control cells (compare
lane1,2 and 3,4), suggesting that the proximal poly(A) site
usage increased and the distal poly(A) site usage decreased
in CFIm25 knocked-down cells. We could not obtain a longer
band with F1 primer, which would represent the distal poly(A)
site. With speciﬁc primer sets, GAPDH mRNA was analyzed
as a loading control and CFIm25 mRNA was analyzed to
show that the knock-down was successful (Figure 2E).
Taken together, it was suggested that CFIm may be
involved in alternative polyadenylation.
CFIm affects alternative poly(A) site selection
in syndecan2, ERCC6 and DHFR genes
To determine whether or not participation of CFIm in alterna-
tive poly(A) site selection is restricted to TIMP-2 gene, we
also analyzed by northern blotting syndecan2 (18), ERCC6
(19) and DHFR genes (20–22), all of which possess multiple
poly(A) sites in their 30-UTRs.
In HeLa cells, there are three syndecan2 transcripts of 1.3,
2.4 and 3.7 kb derived from three poly(A) sites (18). We
found that syndecan2 mRNA patterns were drastically altered
following RNAi-mediated depletion of CFIm25. As shown
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Figure 1. (A) A rabbit polyclonal antibody was raised against GST-CFIm25.
A glutathione S-transferase (GST)-fusion protein of CFIm25 was expressed in
E.coli and purified by affinity chromatography on glutathione Sepharose
(GE Healthcare). HeLa whole cell extracts (20 mg) were separated on 12%
SDS–polyacrylamide gels and analyzed by western blotting with pre-immune
serum (lane 1) or anti-serum (lane 2). The arrowhead at right indicates
CFIm25. (B) Knock-down of CFIm25. Two siRNAs (siRNA-408 and siRNA-
613) were designed to target CFIm25. Whole cell extracts (20 mg) from
mock-transfected (lane 1), siRNA transfected (control siRNA for lane 2,
siRNA-408 for lane 3, siRNA-613 for lane 4) HeLa cells were subjected to
western blot analysis with a-CFIm25, a-CstF-64 and a-actin antibodies.
Actin was served as a loading control.
6266 Nucleic Acids Research, 2006, Vol. 34, No. 21in Figure 3A, the 2.4 kb mRNA was most abundant in control
HeLa cells, while the 1.3 and the 3.7 kb mRNAs were minor.
However, when CFIm was knocked down, the 1.3 kb mRNA
became predominant and the 2.4 and 3.7 kb mRNAs were
greatly reduced, suggesting that alternative poly(A) site
selection was affected.
ERCC6 is known to possess two poly(A) sites in the
30-UTR, resulting in 7.0 and 5.0 kb mRNAs (19). Northern
blotting analysis showed that the 7.0 kb mRNA was detecta-
ble in control HeLa cells and the 5.0 kb was undetectable
(Figure 3B, lane 1), indicating that the downstream site was
preferentially used and the upstream site was rarely used in
HeLa cells. However, when CFIm25 was knocked down,
the 5.0 kb mRNA turned to be detectable, while the 7.0 kb
mRNA became a minor species (Figure 3B), suggesting
that the potential poly(A) site was used when CFIm25 was
knocked down in HeLa cells. These observations indicate
that CFIm may regulate poly(A) site selection but not
mRNA stability.
Remarkable changes in DHFR mRNA patterns were also
detected in knock-down cells. DHFR gene is reported to pos-
sess multiple poly(A) sites in its 30-UTR (20–22), and we
detected ﬁve mRNA species of 1.0, 1.2, 1.4, 3.9 and 4.2 kb
in control HeLa cells by northern blotting (Figure 3C). In
contrast, in knock-down cells the 1.0, 1.2 and 1.4 kb
mRNA species increased while the 3.9 and 4.2 kb species
decreased relative to control cells, indicating that alternative
poly(A) site selection was affected (Figure 3C).
We have reproduced the results of northern blotting experi-
ments that knockdown of CFIm25 altered poly(A) site selec-
tion at least three times for each gene. Taken together,
these observations of the three mRNAs suggest that CFIm
may function in alternative poly(A) site selection in the
30-UTRs.
CFIm does not alter splicing of DHFR gene transcripts
in HeLa cells
The fact that CFIm68 and CFIm59 are SR proteins suggests
a possible participation of CFIm in splicing (23–25). To
exclude this possibility, we performed RT–PCR analysis of
CFIm25 knockdown cells and control HeLa cells using
DHFR primers. Poly(A)
+ RNA isolated from CFIm25
knock-down or control cells were reverse transcribed using
an oligo-dT primer and ampliﬁed using DHFR primers
shown in Figure 4A. As shown in Figure 4B, a single band
was ampliﬁed in control and knock-down cells. Furthermore,
Figure 2. Analysis of CFIm25 knock-down on TIMP-2 mRNAs in HeLa cells
by northern blotting and 30 RACE PCR. (A) The TIMP-2 mRNA structures
are diagramed. Black boxes indicate open reading frame. The arrowheads
indicate proximal and distal poly(A) sites (1077 and 3650). Shaded boxes
indicate UTRs and arrows indicate the F1 primer (400–419) and F2 primer
(2777–2796) in 30 RACE experiments. (B) Northern blotting analysis on
TIMP-2 mRNAs. Poly(A)
+ RNA from mock-transfected (lane 1), siRNA
transfected (siRNA-control for lane 2, siRNA-408 for lane 3 and siRNA-613
for lane 4) HeLa cells were analyzed by northern blotting with a TIMP-2
probe. RNA size markers are indicated on the left. Quantification is shown in
the lower panel, relative to the 1.2 kb signal in lane1. (C) Northern analysis
with a b-actin cDNA probe, serving as a loading control. (D)3 0 RACE PCR
experiments. Specific primers F1 and F2 were used for the amplification of
the 3.8 kb mRNA 30 ends (upper panel) and the 1.2 kb mRNA 30 end (middle
panel), respectively. Lane 1 mock-transfected, lane 2 control siRNA, lane 3
siRNA-408 and lane 4 siRNA-613 transfected. Quantification is shown in the
lower panel, relative to the signals in lane 1. (E) RT–PCR experiments.
CF1m25 (upper panel) was analyzed to show the knock-down efficiency and
GAPDH (lower panel) was analyzed for the loading control.
Nucleic Acids Research, 2006, Vol. 34, No. 21 6267Figure 3. Northern blotting analysis on syndecan2 (A), ERCC6 (B) and DHFR (C) transcripts. Poly(A)
+ RNA from control (lanes 1 and 2) or from CFIm25
knocked-down (lanes 3 and 4) cells was immobilized on a membrane and analyzed using following cDNA probes: syndecan2 (A), ERCC6 (B) and DHFR (C).
Lane 1 mock-transfected, lane 2 control siRNA transfected, lane 3 siRNA-408 transfected, lane 4 siRNA-613 transfected. Quantifications are shown in the lower
panels, relative to the 2.4 kb signal in lane 1 (syndecan2), the 7.0 kb signal in lane 1 (ERCC6) and the 1.2 kb signal in lane 1 (DHFR). RNA size markers are
indicated at left.
6268 Nucleic Acids Research, 2006, Vol. 34, No. 21western blotting analysis with a DHFR antibody of whole cell
extracts derived from control and CFIm25 knock-down cells
detected a single band (data not shown), suggesting that
CFIm dose not participate in alternative splicing of DHFR
transcripts in HeLa cells.
CFIm25 has tandem multiple poly(A) signals in its
30-UTR
It is known that alternative poly(A) site selection sometimes
occurs in a tissue speciﬁc fashion (see Supplementary Figure)
(5), which may be mediated in part by tissue speciﬁc expres-
sion of 30 end processing factors. To determine if CFIm25
functions in such a tissue speciﬁc manner, we examined its
expression proﬁle in human tissues.
Northern blotting analysis of eight different tissues
revealed 1.1, 2.0 and 4.6 kb CFIm25 transcripts. In those
human tissues examined, the 4.6 kb mRNA was ubiquitously
expressed, but the 1.1 and 2.0 kb mRNAs were expressed in
a tissue speciﬁc fashion (Figure 5A). Speciﬁcally the 1.1 kb
mRNA was highly expressed in heart, liver and skeletal
muscle, and the 2.0 kb mRNA species was detectable in
heart, liver, skeletal muscle, kidney and pancreas. The three
mRNAs were also detected in HeLa cells (Figure 5B). To
characterize the three mRNAs, we analyzed EST databases
and found that there are at least three different poly(A)
sites, with canonical poly(A) signals, in CFIm25 gene
(NCBI: BG753954, BI260021 and DB558396). The three
mRNAs were further analyzed computationally, and we found
that the three cleavage sites are located in the 30-UTR, 82,
1040 and 3579 nt downstream from the stop codon, respec-
tively. Moreover, we found that the calculated mRNA sizes
exactly matched the bands detected by northern blotting
analysis, suggesting that the three mRNAs represent the
three poly(A) sites in the CFIm25 30-UTR.
Taken together, these results indicate that CFIm25 is
ubiquitously expressed in human tissues and there are three
likely poly(A) sites in its 30-UTR.
DISCUSSION
Here, we present in vivo evidence that CFIm regulates
alternative poly(A) site selection of genes with tandem
poly(A) signals in their 30-UTRs.
Alternative poly(A) site selection is widely employed in
mammalian cells to regulate gene expression (1,2,26). Alter-
native poly(A) sites can be located in the last or 30-most exon,
usually giving rise to mRNAs with variable 30-UTRs, or in a
different exon leading to distinct protein products. In terms of
alternative polyadenylation, one of the best studied examples
is the IgM heavy chain gene (13,14,27–32). During B
lymphocyte activation, the IgM heavy chain gene switches
from using one poly(A) site to another, resulting in a shift
in protein production from a membrane-bound to a secreted
form following the deletion of a C-terminal membrane
interaction region. An increase in CstF-64 levels during the
transition of resting B cells to proliferating B lymphoblasts
causes preferential use of an upstream signal (13). Although
many genes that possess multiple poly(A) sites within the
Figure 4. RT–PCR analysis. (A) The DHFR gene structure is diagramed.
Black boxes indicate exons. Primer sets used for PCR are shown. (B)
Poly(A)
+ RNA from control mock-transfected (lane 1) or from siRNA-408
and siRNA-613 transfected CFIm25 knocked-down (lanes 2 and 3) HeLa
cells were reverse transcribed using an oligo-dT primer, and then DHFR
cDNA fragments were amplified by PCR. A 100 bp DNA ladder was loaded
in lane M.
Figure 5. (A) Tissue specific expression of CFIm25. A human MTN blot
membrane containing approximately 2.0 mg of poly(A)
+ RNA per lane from
eight different human tissues was analyzed by northern blotting (lane 1, heart;
lane 2, brain; lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, skeletal
muscle; lane 7, kidney and lane 8, pancreas). Three transcripts of 1.1, 2.0 and
4.6 kb were detected. (B) Approximately 2.5 mg of poly(A)
+ RNA from HeLa
cells were analyzed using the CFIm25 probe. Three transcripts of 1.1, 2.0 and
4.6 kb were detected. (C) The gene structure of CFIm25 is diagramed. Black
boxes indicate exons. Arrows indicate likely poly(A) sites.
Nucleic Acids Research, 2006, Vol. 34, No. 21 626930-UTR have been reported and characterized (1), the
molecular basis for alternative polyadenylation in a 30-UTR
has remained unknown. We show here that CFIm is involved
in alternative selection among tandem arrays of poly(A)
signals within a single 30-UTR.
In this article, we analyzed TIMP-2, syndecan2, ERCC6
and DHFR genes that have multiple poly(A) signals in their
30-UTRs (17–22). In addition to these genes, we also investi-
gated for alpha-tropomyosin and vesl genes (33–35) in HeLa
cells whose alternative poly(A) sites are located in a body of
genes. In these genes, we did not observe alternative poly(A)
site selection following CFIm knock-down (data not shown).
At this point we cannot determine whether CFIm serves a role
for selection of poly(A) sites located within a body of genes.
What is the meaning of alternative poly(A) site selection in
a single 30-UTR? In our experiments, we observed that CFIm
depletion in HeLa cells did not affect the cell viability.
This may be explained by the fact that HeLa cells can
often overcome some defects that would otherwise be critical.
We speculate that alternative polyadenylation may most
impact in cooperation with some regulatory factors. Recently
it was demonstrated that there are many regulatory elements
in a 30-UTR (36,37). For example, mRNA stability is
controlled by AU rich elements in the 30-UTR (38) and
microRNAs target the 30-UTR to inhibit translation (39,40).
The regulation by microRNA occurs frequently in develop-
ment and in cellular differentiation. We took an advantage
of knocking down zCFIm25 (NCBI: AAH53172. 97% ident-
ical to hCFIm25) in fertilized zebraﬁsh eggs by morpholino
oligonucleotide (MO) and observed some morphological
defects, suggesting that CFIm may function in embryogenesis
(T. Kubo and T. Wada, unpublished data).
Interestingly, the northern blotting analysis of CFIm25
expression in human tissues demonstrated that in addition
to the predominant mRNA species, the CFIm25 gene was
transcribed as several minor mRNAs, likely resulting from
use of multiple poly(A) sites in the 30-UTR. The CFIm25
30-UTR structure is conserved between humans and mice
(data not shown), suggesting that the alternative polyade-
nylation may be similarly regulated. Thus we attempted to
investigate for an auto-regulation mechanism of poly(A)
site selection (41,42). Since siRNA destabilizes mRNA itself,
we took an approach of synthesizing MO against CFIm25,
which blocks translation but not decays mRNA. So far, low
efﬁciency of delivering MO to HeLa cells prevented us from
succeeding in blocking translation of CFIm25.
In the four genes analyzed, CFIm knockdown inﬂuenced
preferential use of polyadenylation sites upstream of those
favored in control cells within 30-UTR. Since CFIm is an
essential 30 end processing factor, our initial prediction
was that CFIm depletion by RNAi would reduce efﬁcient
pre-mRNA cleavage, resulting in an appearance of longer
transcripts. However, in all genes tested, we observed
increases in upstream poly(A) site usage following CFIm25
knock-down, leading us to hypothesize that CFIm suppresses
pre-mRNA cleavage. This idea has also been proposed by
Gilmartin and colleagues (11). In that work, increasing levels
of CFIm68/25 suppressed pre-mRNA cleavage in vitro (11).
Given that CPSF and CstF are present throughout the tran-
scription unit, there should be a mechanism to restrict access
of 30 end processing factors to nascent RNA (12,43,44).
We favor the idea that CFIm may play a role in regulating
RNA binding of CPSF and CstF. Moreover, our results in
TIMP-2, syndecan2 and ERCC6 indicate that in the presence
of CFIm the most upstream poly(A) sites in the terminal
exons are not primarily used in HeLa cells, while in the
absence of CFIm the most upstream poly(A) sites predomi-
nate. In this context, we speculate that CFIm may serve a
role for recognizing the most upstream poly(A) site in a ter-
minal exon. The terminal exon deﬁnition has been predicted
to occur by communication between 30 splice site and
poly(A) signal (45–47), which are recognized by splicing
factors and 30 end processing factors, respectively. Interaction
of CFIm with splicing factors may contribute to selection of
poly(A) sites in the terminal exon (11,23–25). CFIm may
inhibit pre-mRNA cleavage, recognizing the most upstream
poly(A) site within a terminal exon through physical inter-
actions with splicing factors and other processing factors.
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